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Abstract
Methicillin-resistant Staphylococcus aureus (MRSA) is an established nosocomial pathogen with frequent multidrug
resistance. The immaturity of the immune system along with intravascular lines and empirical antibiotic treatments
place hospitalized preterm infants at major risk of MRSA infection.
We report a case of MRSA mandibular osteomyelitis complicating a persistent S. aureus bacteremia in a 23-week
preterm infant. From the first weeks of life, the infant showed recurrent C-reactive protein (CRP) elevation, associated
with S. aureus bacteremia. Antibiotic courses, including vancomycin and linezolid, were performed with transitory
normalization of blood parameters. On day 74, the infant suddenly deteriorated and showed a significant increase of
both CRP and procalcitonin. Empiric vancomycin and piperacillin-tazobactam treatment was started; nevertheless, she
developed a progressive hard swelling of neck and mandible. Radiological evaluation revealed a mandibular
osteomyelitis complicated by an abscess, whose culture grew MRSA. Vancomycin was thus changed to teicoplanin and
complete clinical and radiological healing was gradually achieved.
In the presence of major risk factors, persistent bacteremia and nonspecific symptoms, a localized focus of infection
should be suspected. Microbiological diagnosis should always be attempted and antibiotic treatment should be
guided by both susceptibility results and clinical response.
Background
Staphylococcus aureus is a facultative anaerobic Gram-
positive bacterium. From the 1970s on, S. aureus strains
resistant to beta-lactam antibiotics, called methicillin-
resistant S. aureus (MRSA), have progressively emerged.
These strains are typical nosocomial pathogens and
often show multidrug resistance patterns.
The immaturity of the immune system, along with the
widespread use of empirical antibiotic treatments, intravas-
cular lines and other invasive devices in Neonatal Intensive
Care Units, places preterm infants at great risk of MRSA
infection. Colonized hospitalized neonates are 24.2 times
more likely to develop an ensuing MRSA infection when
compared with non-colonized [1].
We present a case of MRSA mandibular osteomyelitis
complicating a persistent S. aureus bacteremia in an ex-
tremely low birth weight (ELBW) preterm infant.
Case presentation
This 498-grams Caucasian female infant was born in
April 2012 at 23 + 4 weeks of gestation by emergency
cesarean section due to abruptio placentae. Apgar scores:
5–8. During the first weeks of life, she remained in critical
condition; prolonged mechanical ventilation and total par-
enteral nutrition were required.
On day 28, the infant showed clinical deterioration and re-
spiratory instability. Blood tests revealed a C-reactive Protein
(CRP) increase (4.26 mg/dl). The ongoing percutaneous
central venous catheter (PCVC) was replaced (indwelling
time [IT]: 14 days) and blood cultures were performed sim-
ultaneously. Both PCVC tip and blood cultures resulted
negative, whereas a real-time multiplex polymerase chain re-
action (PCR) diagnostic test (SeptiFast™) was positive for S.
aureus. According to the isolate, treatment with vancomycin
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(15 mg/kg twice daily) was started and continued up to day
of life (DOL) 40, with subsequent CRP normalization.
At DOL 46 blood tests routinely performed showed a
CRP increase (8.51 mg/dl). PCVC was replaced (IT: 18 days)
and treatment with meropenem (20 mg/kg thrice daily)
and vancomycin (15 mg/kg twice daily) was started.
Septifast specimen was positive for S. aureus, whereas
blood and PCVC tip cultures showed negative. After an
initial decrease, on day 51 CRP rose again (4.41 mg/dl) and
the infant developed respiratory instability with increased
oxygen need. On this basis, vancomycin was changed to li-
nezolid (10 mg/kg thrice daily). Seven days later linezolid
was discontinued, whereas meropenem was maintained
until DOL 69. During this period, CRP decreased and the
infant improved.
On day 74 (postconceptional age 34 + 2 weeks, body
weight 840 g) the infant suddenly developed lethargy, ab-
dominal distension with bilious gastric residuals, succeed-
ing apneas and bradycardias. Due to respiratory instability,
she was put on mechanical ventilation; moreover, enteral
nutrition was withheld and PCVC was replaced (IT: 8 days).
Blood tests revealed an increase of both CRP (8.35 mg/dl)
and procalcitonin (20.6 ng/ml). After obtaining blood cul-
tures, empiric therapy with vancomycin (15 mg/kg twice
daily) and piperacillin-tazobactam (100 mg/kg thrice daily)
was started.
Twelve hours later, the infant developed a hard swelling
of neck and mandible with heat and redness of the overly-
ing skin. Cranial X-rays revealed an osteolytic lesion of the
right horizontal mandibular ramus surrounded by perios-
teal reaction and soft tissue swelling, consistent with osteo-
myelitis (Fig. 1a). Ultrasound scans confirmed the soft
tissue swelling and detected the presence of a round, sup-
purated area (diameter 15 mm) next to the right horizontal
mandibular ramus (Fig. 1b). Transthoracic echocardiog-
raphy revealed no evidence of endocarditis. Blood tests
were repeated, detecting CRP 23.42 mg/dl and procalcito-
nin 29.3 ng/ml. On this basis, antibiotic therapy with
vancomycin was changed to teicoplanin (15 mg/kg IV bolus
followed by 12 mg/kg after 12 and 24 hours; followed by
10 mg/kg daily) while piperacillin-tazobactam was modified
to continuous infusion (400 mg/kg/24 h). A transitory
leucopenia (white blood cell count 3,900/mm3, of which
neutrophils 2,540/mm3 and lymphocytes 680/mm3) associ-
ated with piperacillin-tazobactam treatment was observed
on day 76. PCVC tip and blood cultures previously sent
both showed negative.
At DOL 78 a craniofacial contrast computerized
tomography (CT) scan was performed (Fig. 2). Bone
window setting documented loss of structural bone in-
tegrity with cortical disruption mainly involving the
right mandibular horizontal ramus. Soft-tissue window
setting confirmed the inflammatory edema and showed a
hypodense fluid area with peripheral contrast enhancement
next to the right mandibular ramus, consistent with an
abscess.
In the following hours the mandibular swelling further
increased, forming a fluctuant abscess. Surgical drainage
was planned; however, on day 79 the abscess spontaneously
fistulated through the chin skin, draining 10 ml of
purulent material, whose culture grew MRSA (minimum
inhibitory concentrations [MICs]: oxacillin >2 mg/dl,
penicillin >8 mg/dl, vancomycin >1 mg/L). Over the fol-
lowing days the infant improved and the mandibular
swelling slowly reduced. CRP values gradually normalized
and blood cultures remained stable negative. Continuous
infusion of piperacillin-tazobactam was stopped at DOL
84 while teicoplanin was continued at the aforementioned
Fig. 1 X-ray and ultrasound evaluations. Facial bone X-rays in lateral
projection (a) showed the osteolytic disruption of the right horizontal
mandibular ramus with focal periosteal reaction and swelling of the
surrounding soft tissues. The ultrasound examination (b) confirmed
X-ray findings and also demonstrated a hypo-anechoic central image
consistent with initial abscess collection
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regimen for a total of 4 weeks, according to Therapeutic
Drug Monitoring plasma levels.
A near-term brain magnetic resonance imaging (MRI)
scan, performed after two months, documented the
complete radiological healing of both soft and bone tis-
sues and displayed intact mandibular alveolar recesses.
The infant was discharged in good condition at DOL 165.
At serial follow-up assessments (6, 12, 18 and 24 months of
corrected age) no recurrence of osteomyelitis was observed
and serum markers of renal function were within normal
ranges. No evidence of missing/malformed mandibular teeth
or delayed dental eruption was noticed.
Discussion
Non-congenital osteomyelitis is rare in the preterm popu-
lation [2–6]. Hematogenous dissemination is the leading
pathophysiological mechanism; intravascular devices are
identified as the main source of infection. S. aureus is the
most common pathogen, with increased rates of MRSA
isolates.
Periosteal reaction, lytic areas surrounded by cortical
thickening and swelling of adjacent soft tissues are com-
mon radiographic findings; in the early phases, however,
plain films may not reveal significant abnormalities. CT is
more sensitive for early osteomyelitis diagnosis [7], being
particularly effective in detecting bone sequestra. Ultra-
sound evaluation is a useful diagnostic tool for identifying
soft tissues swelling, periosteal elevation and fluid collec-
tions next to the affected bone; unfortunately, however, a
normal ultrasound scan can not rule out a diagnosis of
osteomyelitis [8]. Gadolinium-enhanced MRI currently
represents the gold-standard imaging technique for the
early detection of osteomyelitis, complicating abscesses
and related infection of extra-osseous soft tissues [9].
Clinical features of non-congenital osteomyelitis in pre-
term infants have been previously described [3, 6]. Systemic
upset with signs of sepsis is typically present, whereas local
symptoms develop later. Long bones of upper and lower
extremities are mainly interested, with a high risk of long-
term orthopedic sequelae. To date, however, no mandibular
involvement has been reported.
In the present case, the infant required a central access
over a prolonged period. Although the indwelling time of
each PCVC was <20 days, it is feasible that PCVCs repre-
sented the portal entry for MRSA. The extreme prematur-
ity and the infant’s poor weight gain, mainly due to her
critical initial condition, could have further increased sus-
ceptibility to infections.
Even though the collected blood cultures were repeat-
edly negative, the bacterial culture of the purulent
drained material allowed us to ascertain the pathogen
responsible for the mandibular infection. A number of
possible factors could have contributed to negative blood
culture results. Firstly, from the first weeks of life this in-
fant received repeated and prolonged antibiotic treat-
ments. Moreover, a minimum blood volume of 1 mL is
normally required for culture analysis in the neonatal
population; in ELBW infants, however, low blood vol-
ume along with difficult venipuncture are a major chal-
lenge to collecting adequate blood culture specimens. At
small blood volumes, PCR-based diagnostic systems
seem to have a higher sensitivity when compared to
blood cultures [10].
Considering the infant’s major risk factors for MRSA in-
fection (i.e. prematurity, PCVC, previous antibiotic treat-
ments, prolonged hospitalization), S. aureus bacteremia
was firstly treated with vancomycin, which is currently the
mainstay treatment for MRSA infections. Nevertheless, re-
ports of treatment failure are increasing, particularly for
vancomycin MIC > 1 mg/L [11]. Moreover, higher rates of
treatment failure have also been observed in patients with
MRSA bacteremia initially treated with vancomycin [12].
Fig. 2 Axial computerized tomography scans. The bone window setting (a) confirms the large cortical bone erosion of the right mandible; the soft-tissue
window setting (b) shows, next to the mandibular bone, a hypodense area that presents rim enhancement (c) after intravenous contrast medium injection,
consistent with an abscess
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In the present case, vancomycin MIC of the MRSA iso-
lated from the abscess culture was >1 mg/L (established
susceptibility breakpoint: 2 mg/L). However, previous treat-
ments with vancomycin proved to be ineffective in clearing
MRSA bacteremia and preventing possible complications.
We could speculate that, although the isolate showed an in
vitro sensitivity to vancomycin, the infant did not achieve
an adequate clinical response to vancomycin treatment
and developed mandibular osteomyelitis. In consideration
of this fact, and given the lower bone concentration of
vancomycin, antibiotic treatment was finally changed to
teicoplanin with subsequent clinical resolution.
Conclusions
The extreme prematurity of the infant, along with the
characteristics of isolated pathogen and the peculiarity of
the infection site, contribute to the absolute rarity of the
case reported. In the presence of major clinical risk fac-
tors, recurrent CRP elevation, persistent bacteremia and
nonspecific symptoms, a localized focus of infection
should be suspected. Microbiological diagnosis should al-
ways be attempted and antibiotic treatment should be
guided by both susceptibility results and clinical response.
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